Covid-19 vaccine: Bharat BioTech, Ocugen to co-develop Covaxin for US market

- Ocugen will have US rights to the vaccine candidate and, in collaboration with Bharat Biotech, will be responsible for clinical development, registration, and commercialization for the US market